Yüklüyor......
SWL-1 Reverses Fluconazole Resistance in Candida albicans by Regulating the Glycolytic Pathway
Candida albicans is a ubiquitous clinical fungal pathogen. Prolonged use of the first-line antifungal agent fluconazole (FLC) has intensified fungal resistance and limited its effectiveness for the treatment of fungal infections. The combined administration of drugs has been extensively studied and...
Kaydedildi:
| Yayımlandı: | Front Microbiol |
|---|---|
| Asıl Yazarlar: | , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Frontiers Media S.A.
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7596347/ https://ncbi.nlm.nih.gov/pubmed/33178156 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmicb.2020.572608 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|